Sign in

Private company

Vaxxinity, Inc.

Vaxxinity, Inc. is an American pharmaceutical preparations company based in Merritt Island.2

Last updated Oct 21, 2026.

Overview

  • IndustryPharmaceutical Preparations2
  • HeadquartersMerritt Island, United States2
  • Incorporated inFL3
  • Business address505 Odyssey Way, Exploration Park, Fl 329533
  • Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company3
  • Legal formCorporation2
  • LEI529900444BQJFC912P192
  • StatusActive2
  • LEI statusIssued and current2
  • Registered addressc/o CORPORATION SERVICE COMPANY,251 LITTLE FALLS DRIVE, 19808 Wilmington, United States2
  • Registered withDivision of Corporations, Department of State, 46334652

See how the biggest companies compare on our leaderboards

612 was well tolerated with balanced reactogenicity and no additional safety risks evoked over the licensed COVID-19 comparators.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

-100.0%Revenue growth, 20225
-121.0%Return on equity6
-$57.8MFree cash flow6

Financial statements

Revenue75$0 in 2022
0$200.0K$400.0K$600.0K2020: $557.0K$557.0K20202021: $66.0K$66.0K2021−88%2022: $0$02022
Gross profit75$0 in 2022
-$2.0M-$1.0M0$1.0M2020: $505.0K$505.0K20202021: -$1.9M-$1.9M20212022: $0$02022−100%
Operating income756-$76.0M in 2022+135% since 2020
-$150.0M-$100.0M-$50.0M02020: -$32.3M-$32.3M20202021: -$125.1M-$125.1M2021+287%2022: -$76.0M-$76.0M2022−39%
Net income756-$75.2M in 2022+88% since 2020
-$150.0M-$100.0M-$50.0M02020: -$40.0M-$40.0M20202021: -$137.2M-$137.2M2021+243%2022: -$75.2M-$75.2M2022−45%
Fiscal year2019202020212022
Revenue$557.0K7$66.0K5$05
Cost of revenue$52.0K7$1.9M5$05
Gross profit$505.0K7-$1.9M5$05
Research and development$20.6M7$71.4M5$47.6M6
Operating expenses$123.2M5$76.0M6
Operating income-$32.3M7-$125.1M5-$76.0M6
Interest$1.2M7$840.0K5$514.0K6
Income before tax-$137.2M5-$75.2M6
Income tax$07$05$05
Net income-$40.0M7-$137.2M5-$75.2M6
Earnings per share-$1.795-$0.606
Earnings per share (diluted)-$1.795-$0.606
Shares (weighted, basic)76.6M shares5125.9M shares6
Shares (weighted, diluted)76.6M shares5125.9M shares6

Compare Vaxxinity, Inc. with another company

Corporate structure

Vaxxinity, Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Vaxxinity, Inc.

  • Lou Reese Filed SC 13G/A on Vaxxinity, Inc., latest Feb 12, 2024 (2 filings since Apr 27, 2022)
  • Mei Mei Hu Filed SC 13G/A on Vaxxinity, Inc., latest Feb 12, 2024 (3 filings since Apr 27, 2022)
  • Prime Movers Lab Fund I LP Filed SC 13G/A on Vaxxinity, Inc., latest Feb 7, 2024 (3 filings since Feb 9, 2022)
  • UNITED BIOMEDICAL INC Filed SC 13G/A on Vaxxinity, Inc., latest Jan 27, 2023 (2 filings since Apr 27, 2022)
  • Vaxxinity, Inc. Merritt Island, Florida, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Vaxxinity, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$16.9M6 Dec 31, 2023$16.1M6 Dec 31, 2022+5.0%
Accumulated depreciation$5.9M6 Dec 31, 2023$3.6M6 Dec 31, 2022+61.9%
Property and equipment, net$11.1M6 Dec 31, 2023$12.5M6 Dec 31, 2022−11.4%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$4.9M6 Dec 31, 2023$33.5M6 Dec 31, 2022−85.3%
Marketable securities, current$25.5M6 Dec 31, 2023$53.4M6 Dec 31, 2022−52.3%

Leadership

Who has led Vaxxinity, Inc., and when. Pick a name to see everywhere that person has worked.

Chair

  1. Lou Reese2021–2022
2025
Board members and other officers (14)

Timeline

  1. Apr 19, 20248-K Listing notice or transfer; Other events25
  2. Mar 14, 20248-K Executive or director change; Shareholder vote26
  3. Feb 15, 20248-K Listing notice or transfer27
  4. Dec 1, 20238-K Executive or director change28
  5. Sep 28, 20238-K Change of auditor; Executive or director change; Other events29
  6. Jul 27, 20238-K Change of auditor; Executive or director change; Other events30
  7. Jun 22, 20238-K Shareholder vote31
  8. Feb 3, 20238-K Executive or director change32
  9. Jun 24, 20228-K Shareholder vote33
  10. Mar 28, 20228-K Results of operations34
  11. Mar 22, 20228-K Executive or director change; Director nominations; Regulation FD disclosure35
  12. Jan 4, 20228-K Executive or director change; Regulation FD disclosure36
  13. Feb 2, 2021Founded Vaxxinity, Inc. is founded2

Calendar

When it reported results

  1. Mar 28, 2022Reported quarterly or annual results34

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

186 filings to the SEC since October 2021: 4 annual reports, 7 quarterly reports, 13 major events, 83 insider forms, 10 large holders, 69 other. The latest 20:

  1. May 9, 202415-12G EDGAR
  2. May 9, 2024DEF 14C EDGAR
  3. May 2, 2024EFFECT EDGAR
  4. Apr 30, 2024S-8 POS EDGAR
  5. Apr 30, 2024S-8 POS EDGAR
  6. Apr 30, 2024POS AM EDGAR
  7. Apr 29, 202410-K/A EDGAR
  8. Apr 29, 2024PRE 14C EDGAR
  9. Apr 29, 202425 EDGAR
  10. Apr 29, 20244 EDGAR
  11. Apr 19, 20248-K EDGAR
  12. Mar 27, 202410-K EDGAR
  13. Mar 14, 20248-K FORM 8K EDGAR
  14. Feb 15, 20248-K EDGAR
  15. Feb 12, 2024SC 13G/A EDGAR
  16. Feb 12, 2024SC 13G/A EDGAR
  17. Feb 7, 2024SC 13G/A EDGAR
  18. Dec 1, 20238-K EDGAR
  19. Nov 30, 2023144 EDGAR
  20. Nov 30, 2023144 EDGAR

The 186 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

38 open-market trades by officers, directors and large owners since October 2021: 25 buys and 13 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 8, 2023Prime Movers Lab Fund I LP10% ownerSale47,961$1.67$80.1KForm 4
Sep 7, 2023Prime Movers Lab Fund I LP10% ownerSale38,828$1.79$69.5KForm 4
Sep 6, 2023Prime Movers Lab Fund I LP10% ownerSale10,147$1.88$19.1KForm 4
Jan 23, 2023Sloss Dakin10% ownerSale500,692$3.35$1.7MForm 4
Dec 2, 2022Prime Movers Lab Fund I LP10% ownerSale13,741$2.57$35.3KForm 4
Dec 1, 2022Prime Movers Lab Fund I LP10% ownerSale334,807$2.97$994.4KForm 4
Sep 6, 2022Sloss Dakin10% ownerSale37,358$2.40$89.7KForm 4
Aug 25, 2022Prime Movers Lab Fund I LP10% ownerSale33,680$2.33$78.5KForm 4
Aug 24, 2022Prime Movers Lab Fund I LP10% ownerSale124,000$2.39$296.4KForm 4
Aug 23, 2022Prime Movers Lab Fund I LP10% ownerSale50,000$2.45$122.5KForm 4
Jun 16, 2022Reese LouSee RemarksBuy100,000$1.99$199.0KForm 4
Jun 16, 2022Hu Mei MeiSee RemarksBuy100,000$1.99$199.0KForm 4
Jun 16, 2022UNITED BIOMEDICAL INC10% ownerBuy100,000$1.99$199.0KForm 4
Jun 13, 2022Prime Movers Lab Fund I LP10% ownerSale137,000$2.43$332.9KForm 4
Jun 10, 2022Prime Movers Lab Fund I LP10% ownerSale42,000$2.80$117.6KForm 4
Jun 9, 2022UNITED BIOMEDICAL INC10% ownerBuy10,978$2.72$29.9KForm 4
Jun 9, 2022Hu Mei MeiSee RemarksBuy10,978$2.72$29.9KForm 4
Jun 9, 2022Reese LouSee RemarksBuy10,978$2.72$29.9KForm 4
Jun 8, 2022UNITED BIOMEDICAL INC10% ownerBuy10,000$2.95$29.5KForm 4
Jun 8, 2022Hu Mei MeiSee RemarksBuy10,000$2.95$29.5KForm 4

All 38 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Vaxxinity, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARVaxxinity, Inc.1
  • CIK0001851657
  • Employer ID (EIN)86-20838651
  • Filer statusNon-accelerated filer<br>smaller reporting company<br>emerging growth company1
  • Incorporated inFlorida1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address505 Odyssey Way, Exploration Park, FL 329531
  • Phone(254) 244-57391
  • Shares outstanding126,784,684 as of Apr 26, 202441
  • Public float$155.6M as of Jun 30, 202341
  • On EDGAR sinceMar 17, 20211
  • Filings210 in all: 4 (59), 144 (47), 3 (19), 8-K (13), 10-Q (7), CORRESP (7), SC 13G/A (6), UPLOAD (6)1
    All 36 form types

    S-8 POS (4), SC 13G (4), 10-K (3), 4/A (3), EFFECT (3), 3/A (2), D (2), DEF 14A (2), DEFA14A (2), DRSLTR (2), S-8 (2), 10-K/A (1), 15-12G (1), 25 (1), 424B3 (1), 424B4 (1), 8-A12B (1), ARS (1), CERT (1), DEF 14C (1), DRS (1), DRS/A (1), FWP (1), POS AM (1), PRE 14C (1), S-1 (1), S-1/A (1), S-3 (1)

  • Latest filingsAnnual report (10-K) Mar 27, 2024
    Quarterly report (10-Q) Nov 8, 2023
    Proxy statement (DEF 14A) Apr 28, 2023
    Latest 8-K (8-K) Apr 19, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41